Literature DB >> 19558766

Supervised exercise for intermittent claudication - an under-utilised tool.

Joseph Shalhoub1, Maher Hamish, Alun H Davies.   

Abstract

INTRODUCTION: The use of supervised exercise in the management of intermittent claudication is well supported by level I evidence upon which are based grade A recommendations by the TASC II Inter-Society Consensus for the Management of Peripheral Arterial Disease and the Scottish Intercollegiate Guidelines Network (SIGN). These include that supervised exercise should be made available as part of the initial treatment for all peripheral arteriopaths. SUBJECTS AND METHODS: A questionnaire, comprising 10 questions, was drawn up to address the issues pertinent to supervised exercise in intermittent claudication. This was distributed by post, along with a pre-stamped return envelope, to all ordinary members of the Vascular Society of Great Britain and Ireland (VSGBI). All returned and received questionnaires had their responses entered onto a pre-prepared spreadsheet.
RESULTS: Of the 186 questionnaires posted to UK resident surgeons, 84 were returned. This equates to a response rate of 45%. Of the responders, only 24% had access to supervised exercise. There was a large spread in the proportion of eligible patients which were referred to a programme, with only 14% of VSGBI members recommending 100% of eligible patients. Rates of non-compliance varied greatly. Contra-indications to supervised exercise included cardiac (27%), and vascular, musculoskeletal, geographic, and respiratory (8% each). Most supervised exercise sessions (85%) were 1 h in duration. The majority (65%) of programmes comprised one session per week. With regards the duration of programme, 55% were 3 months. Almost all classes were led by either a physiotherapist (41%) or a nurse (48%). In centres where no supervised exercise programme was available, verbal advice was given by 63%, with 34% offering leaflets. A supervised exercise set up has not been achieved due to lack of resource in 72%.
CONCLUSIONS: These results are contrary to the recommendations offered by the TASC II Inter-Society Consensus and SIGN, in particular in terms of availability and referral to supervised exercise, as well as frequency of the classes where programmes were in place. The offer of information either verbally or via leaflet is commended; however, this has been shown as inferior to supervised exercise. Quoting resource as the reason for non-implementation goes against the published quality-of-life and pharmaco-economic data, which promote supervised exercise as both functionally and financially effective. This work highlights the importance of translating the results of research into evidence-based clinical practice.

Entities:  

Mesh:

Year:  2009        PMID: 19558766      PMCID: PMC2966198          DOI: 10.1308/003588409X432149

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  17 in total

1.  Physical training for intermittent claudication: a comparison of structured rehabilitation versus home-based training.

Authors:  Steve Degischer; Karl-Heinz Labs; Jacques Hochstrasser; Markus Aschwanden; Martin Tschoepl; Kurt A Jaeger
Journal:  Vasc Med       Date:  2002-05       Impact factor: 3.239

Review 2.  Exercise therapy and the additional effect of supervision on exercise therapy in patients with intermittent claudication. Systematic review of randomised controlled trials.

Authors:  J Wind; M J W Koelemay
Journal:  Eur J Vasc Endovasc Surg       Date:  2007-02-27       Impact factor: 7.069

Review 3.  A review of the clinical effectiveness of exercise therapy for intermittent claudication.

Authors:  E Ernst; V Fialka
Journal:  Arch Intern Med       Date:  1993-10-25

Review 4.  Exercise for intermittent claudication.

Authors:  G C Leng; B Fowler; E Ernst
Journal:  Cochrane Database Syst Rev       Date:  2000

5.  Effects of exercise training program on functional capacity and quality of life in patients with peripheral arterial occlusive disease. Evaluation of a pilot project.

Authors:  Ch Gartenmann; I Kirchberger; M Herzig; I Baumgartner; H Saner; F Mahler; K Meyer
Journal:  Vasa       Date:  2002-02       Impact factor: 1.961

6.  Intermittent claudication: pharmacoeconomic and quality-of-life aspects of treatment.

Authors:  Gregorio Brevetti; Roberta Annecchini; Roxanna Bucur
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

7.  Does supervised exercise offer adjuvant benefit over exercise advice alone for the treatment of intermittent claudication? A randomised trial.

Authors:  D R Cheetham; L Burgess; M Ellis; A Williams; R M Greenhalgh; A H Davies
Journal:  Eur J Vasc Endovasc Surg       Date:  2004-01       Impact factor: 7.069

8.  Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response.

Authors:  W R Hiatt; E E Wolfel; R H Meier; J G Regensteiner
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

9.  Exercise training improves functional status in patients with peripheral arterial disease.

Authors:  J G Regensteiner; J F Steiner; W R Hiatt
Journal:  J Vasc Surg       Date:  1996-01       Impact factor: 4.268

10.  Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis.

Authors:  A W Gardner; E T Poehlman
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272

View more
  6 in total

1.  The Group Oriented Arterial Leg Study (GOALS) to improve walking performance in patients with peripheral arterial disease.

Authors:  Mary M McDermott; Kathryn Domanchuk; Kiang Liu; Jack M Guralnik; Lu Tian; Michael H Criqui; Luigi Ferrucci; Melina Kibbe; Donald-Lloyd Jones; William H Pearce; Lihui Zhao; Bonnie Spring; W Jack Rejeski
Journal:  Contemp Clin Trials       Date:  2012-08-07       Impact factor: 2.226

2.  Exercise therapy in routine management of peripheral arterial disease and intermittent claudication: a scoping review.

Authors:  Ukachukwu O Abaraogu; Onyinyechukwu D Abaraogu; Philippa M Dall; Garry Tew; Wesley Stuart; Julie Brittenden; Chris A Seenan
Journal:  Ther Adv Cardiovasc Dis       Date:  2020 Jan-Dec

3.  Protocol for a prospective, longitudinal cohort study on the effect of arterial disease level on the outcomes of supervised exercise in intermittent claudication: the ELECT Registry.

Authors:  Marijn Ml van den Houten; Sandra Cp Jansen; Anneroos Sinnige; Lijckle van der Laan; Patrick Whe Vriens; Edith M Willigendael; Jan-Willem Hp Lardenoije; Jan-Willem M Elshof; Eline S van Hattum; Maarten A Lijkwan; Ivan Nyklíček; Ellen V Rouwet; Mark Jw Koelemay; Marc Rm Scheltinga; Joep Aw Teijink
Journal:  BMJ Open       Date:  2019-02-19       Impact factor: 2.692

4.  The Disruption of Trust in the Digital Transformation Leading to Health 4.0.

Authors:  Michael Guckert; Kristina Milanovic; Jennifer Hannig; David Simon; Tamara Wettengl; Daniel Evers; Arnd Kleyer; Till Keller; Jeremy Pitt
Journal:  Front Digit Health       Date:  2022-03-28

5.  Incorporating an exercise rehabilitation programme for people with intermittent claudication into an established cardiac rehabilitation service: A protocol for a pilot study.

Authors:  Edward Caldow; Andrew Findlow; Malcolm Granat; Mariyana Schoultz
Journal:  Contemp Clin Trials Commun       Date:  2019-05-27

6.  Feasibility study to evaluate cycloidal vibration therapy for the symptomatic treatment of intermittent claudication.

Authors:  Leanne Atkin; John Stephenson; Karen Ousey
Journal:  Pilot Feasibility Stud       Date:  2019-11-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.